Invention Grant
- Patent Title: Reducing risk of contracting clostridium-difficile associated disease
-
Application No.: US14798276Application Date: 2015-07-13
-
Publication No.: US09862744B2Publication Date: 2018-01-09
- Inventor: Ernesto Abel-Santos , Amber Howerton
- Applicant: The Board of Regents of the Nevada System of Higher Education on Behalf of the University of Nevada, Las Vegas
- Applicant Address: US NV Las Vegas
- Assignee: THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS
- Current Assignee: THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS
- Current Assignee Address: US NV Las Vegas
- Agency: Ballard Spahr LLP
- Main IPC: A61K31/56
- IPC: A61K31/56 ; C07J41/00 ; C07J31/00
Abstract:
A method of treating a patient to reduce risk of developing Clostridium difficile-associated disease or reducing existing Clostridium difficile-associated disease in a mammalian subject involves administering to a mammalian subject an effective amount of a germination-inhibiting compound derived from taurocholate. Novel compounds of this class are also provided.
Public/Granted literature
- US20160009753A1 Reducing Risk of Contracting Clostridium-Difficile Associated Disease Public/Granted day:2016-01-14
Information query
